NO161317C - Analogifremgangsmaate for fremstilling av terapeutisk aktive oksikamer. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive oksikamer.

Info

Publication number
NO161317C
NO161317C NO845145A NO845145A NO161317C NO 161317 C NO161317 C NO 161317C NO 845145 A NO845145 A NO 845145A NO 845145 A NO845145 A NO 845145A NO 161317 C NO161317 C NO 161317C
Authority
NO
Norway
Prior art keywords
oxicams
preparation
therapeutic active
analogue procedure
analogue
Prior art date
Application number
NO845145A
Other languages
English (en)
Other versions
NO845145L (no
NO161317B (no
Inventor
Anthony Marfat
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO845145L publication Critical patent/NO845145L/no
Publication of NO161317B publication Critical patent/NO161317B/no
Publication of NO161317C publication Critical patent/NO161317C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C68/00—Preparation of esters of carbonic or haloformic acids
    • C07C68/02—Preparation of esters of carbonic or haloformic acids from phosgene or haloformates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
NO845145A 1983-12-21 1984-12-20 Analogifremgangsmaate for fremstilling av terapeutisk aktive oksikamer. NO161317C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56390283A 1983-12-21 1983-12-21
US06/606,113 US4551452A (en) 1983-12-21 1984-05-02 Anti-inflammatory 2-methyl-2H-1,2-benzo-(or -thieno-)thiazine-3-carboxamide 1,1-dioxide derivatives, compositions, and method of use therefor

Publications (3)

Publication Number Publication Date
NO845145L NO845145L (no) 1985-06-24
NO161317B NO161317B (no) 1989-04-24
NO161317C true NO161317C (no) 1989-08-02

Family

ID=27073413

Family Applications (1)

Application Number Title Priority Date Filing Date
NO845145A NO161317C (no) 1983-12-21 1984-12-20 Analogifremgangsmaate for fremstilling av terapeutisk aktive oksikamer.

Country Status (26)

Country Link
US (1) US4551452A (no)
EP (1) EP0147177B1 (no)
KR (1) KR860002035B1 (no)
AU (1) AU552940B2 (no)
BG (1) BG47946A3 (no)
CA (1) CA1255302A (no)
DD (1) DD229125A5 (no)
DE (1) DE3466776D1 (no)
DK (1) DK166678B1 (no)
EG (1) EG17049A (no)
ES (1) ES8604215A1 (no)
FI (1) FI79850C (no)
GR (1) GR82512B (no)
HK (1) HK58589A (no)
HU (1) HU201063B (no)
IE (1) IE57680B1 (no)
IL (1) IL73873A (no)
MX (2) MX174596B (no)
NO (1) NO161317C (no)
NZ (1) NZ210632A (no)
PH (1) PH21447A (no)
PL (1) PL145989B1 (no)
PT (1) PT79700B (no)
RO (1) RO90048A (no)
SG (1) SG27001G (no)
YU (1) YU43677B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4778795A (en) * 1983-11-25 1988-10-18 Schering Corporation Carboxyalkyl dipeptides as antiglaucoma agents
US5017567A (en) * 1983-11-25 1991-05-21 Schering Corporation Carboxyalkyl dipeptides as antiglaucoma agents
US4616012A (en) * 1983-11-25 1986-10-07 Schering Corporation Carboxyalkyl dipeptides as antiglaucoma agents
US4906635A (en) * 1983-11-25 1990-03-06 Schering Corporation Carboxyalkyl dipeptides as antiglaucoma agents
US4623486A (en) * 1985-05-29 1986-11-18 Pfizer Inc. [4-substituted benzoyloxy]-N-substituted-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxides having anti-arthritic activity
KR890001236B1 (ko) * 1985-10-02 1989-04-28 화이자 인코포레이티드 소염제 조성물의 제조방법
US4771071A (en) * 1986-05-05 1988-09-13 Merck & Co., Inc. Antihypercholesterolemic compounds
HU199833B (en) * 1986-05-16 1990-03-28 Pfizer Process for producing benzothiazine dioxide derivatives
US5081118A (en) * 1987-10-26 1992-01-14 Pfizer Inc. Benzothiazine dioxide derivatives
IL87951A (en) * 1987-10-29 1992-03-29 Chem Pharm Forsch Gmbh Carbonic acid esters of 6-chloro-4-(1-hydroxyethoxy)-2-methyl-n-(2-pyridyl)-2h-thieno(2,3-e)-1,2-thiazine-3-carboxamide 1,1-dioxide,their preparation and pharmaceutical compositions containing them
ZA945190B (en) * 1993-07-30 1995-02-24 Kotobuki Seiyaku Co Ltd Carboxymethylidenecycloheptimidazole derivatives method or manufacturing the same and therapeutic agents containing these compounds
IT1308633B1 (it) 1999-03-02 2002-01-09 Nicox Sa Nitrossiderivati.
CN100389114C (zh) * 2006-01-17 2008-05-21 南京新港医药有限公司 一种安吡昔康的精制方法
US20090238763A1 (en) * 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
WO2008044095A1 (en) * 2006-10-11 2008-04-17 Techfields Biochem Co. Ltd Positively charged water-soluble prodrugs of oxicams and related compounds with very high skin penetration rate
JP2010529101A (ja) * 2007-06-04 2010-08-26 テックフィールズ インコーポレイテッド 非常に速い皮膚及び膜浸透速度を有するｎｓａｉａプロドラッグ及びその新規医薬使用
KR101946297B1 (ko) 2008-12-04 2019-02-11 충시 위 고투과력을 가진 조성물 및 이의 적용
WO2013093931A2 (en) 2011-09-19 2013-06-27 Sun Pharma Advanced Research Company Ltd. Novel prodrugs of phenolic drugs

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3591584A (en) * 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
US3787324A (en) * 1971-03-01 1974-01-22 Warner Lambert Co 4-hydroxy-3-(3-isoxazolocarbamyl)-2h-1,2-benzothiazine 1,dioxides and process for their production
US3892740A (en) * 1974-10-15 1975-07-01 Pfizer Process for the production of carboxamides of oxo-1,2-benzothiazine-1,1-dioxides
AU518216B2 (en) * 1977-09-06 1981-09-17 Hafslund Nycomed Pharma Aktiengesellschaft Thienothiazine derivatives
US4309427A (en) * 1981-01-15 1982-01-05 Pfizer Inc. Benzothiazine dioxide derivatives
IT1168064B (it) * 1981-11-12 1987-05-20 Prodotti Antibiotici Spa Composto ad azione antinfiammatoria
IT8219486A0 (it) * 1982-02-05 1982-02-05 Chiesi Farma Spa Nuovi composti ad attivita'antiinfiammatoria, procedimento per la loro preparazione e relative composizioni farmaceutiche.

Also Published As

Publication number Publication date
KR850004492A (ko) 1985-07-15
IE57680B1 (en) 1993-02-24
US4551452A (en) 1985-11-05
FI845074L (fi) 1985-06-22
MX174596B (es) 1994-05-30
AU552940B2 (en) 1986-06-26
PL145989B1 (en) 1988-12-31
FI845074A0 (fi) 1984-12-20
PH21447A (en) 1987-10-28
NZ210632A (en) 1987-02-20
DD229125A5 (de) 1985-10-30
EP0147177A3 (en) 1985-08-14
EP0147177B1 (en) 1987-10-14
NO845145L (no) 1985-06-24
EG17049A (en) 1991-03-30
ES538907A0 (es) 1986-01-16
PT79700A (en) 1985-01-01
SG27001G (en) 1989-08-11
NO161317B (no) 1989-04-24
GR82512B (en) 1985-04-22
PT79700B (en) 1986-12-30
YU43677B (en) 1989-10-31
BG47946A3 (en) 1990-10-15
CA1255302A (en) 1989-06-06
DK166678B1 (da) 1993-06-28
YU216084A (en) 1986-10-31
HUT37426A (en) 1985-12-28
MX9203740A (es) 1992-09-01
DK614984D0 (da) 1984-12-20
HU201063B (en) 1990-09-28
IL73873A0 (en) 1985-03-31
KR860002035B1 (ko) 1986-11-17
DE3466776D1 (en) 1987-11-19
HK58589A (en) 1989-07-28
IE843260L (en) 1985-06-21
RO90048A (ro) 1986-09-30
AU3699784A (en) 1985-07-04
FI79850B (fi) 1989-11-30
PL251040A1 (en) 1985-10-22
IL73873A (en) 1988-02-29
FI79850C (fi) 1990-03-12
EP0147177A2 (en) 1985-07-03
ES8604215A1 (es) 1986-01-16
DK614984A (da) 1985-07-17

Similar Documents

Publication Publication Date Title
NO159016C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenetanolaminderivater.
NO164025C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-imidazolylmetyl-tetrahydrokarbazolon-derivater.
NO156785C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklobutan-derivater.
NO871267D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazepinforbindelser.
NO160521C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 13alfa- alkylgonaner.
NO161002C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive polypeptider.
NO874869L (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO165239C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater.
NO165192C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive glyserolderivater.
NO165027C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive propenyl-cefalosporinforbindelser.
NO161317C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oksikamer.
NO161497C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 9a-aza-9a-homoerytromycin-derivater.
NO158876C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive adenosin-derivater.
NO158460C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO161562C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ergolinderivater.
NO159930C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indeno-pyridazinon-derivater.
NO164541C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater.
NO161559C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive triazolderivater.
NO158941C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-piperidino-kinazolinderivater.
NO159090C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater.
NO873680D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfonamido-etyl-forbindelser.
NO163570C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive acylaminomitosaner.
NO162188C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoliner.
NO157618C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzamid-inderivater.
NO163617C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolidinon-derivater.

Legal Events

Date Code Title Description
MK1K Patent expired